Valeant casts brusied egos aside, buys again

target was another generic producer that also had over-the-counter drugs. Earlier in 2010 Valeant also paid $300-million to GlaxoSmithKline to buy the U.S. and Canadian rights for Zovirax, a prescription cream for cold sores. Valeant launched its failed...